Text and Data Mining valid from 2018-08-22
Received: 9 March 2018
Revised: 28 May 2018
Accepted: 28 May 2018
First Online: 22 August 2018
Compliance with ethical standards
: (1) D.A.M.H., P.J.F.S., R.D.M.S., and C.J.L.M.M. are minority shareholders of self-screen B.V., a spin-off company of VUmc; (2) self-screen B.V. holds patents related to the work (i.e., hrHPV test and methylation markers for cervical screening); (3) D.A.M.H. has been on the speaker's bureau of Qiagen and serves occasionally on the scientific advisory boards of Pfizer and Bristol-Meyers Squibb; (4) P.J.F.S. has been on the speakers bureau of Roche diagnostics, Gen-Probe, Abbott, Qiagen and Seegene and has been a consultant for Crucell B.V.; (5) J.B. received consultancy fees from Roche, GlaxoSmithKline, and Merck and received travel support from DDL. All fees were collected by his employer; (6) C.J.L.M.M. served occasionally on the scientific advisory board (expert meeting) of Qiagen and SPMSD/Merck, and has by occasion been consultant for Qiagen; he has been co- investigator on a Sanofi Pasteur/MSD sponsored HPV vaccination trial in men of which his institute received research funding; (7) C.J.L.M.M. has small number of shares of Qiagen, is minority shareholder of Self-Screen bv of which he is part-time director since sept 2017. He was minority shareholder of Diassay B.V. until April 2016; (8) M.V.Z., W.W.K., A.L., M.C.G.B., D.J., J.D., and G.G.K. declare that they have no conflict of interest.